Interestingly, our results differed from previous reports which indicated that SIRT1 serves as a positive regulator of epithelial-mesenchymal transition, the metastatic growth of prostate cancer cells [62], and is associated with malignancy in chronic myelogenous leukemia [63]. This evidence concerns the gene SIRT1 and Familial prostate cancer.